Template:Ergotamine: Difference between revisions

Jump to navigation Jump to search
VisualWikitext
No edit summary
No edit summary
 
(4 intermediate revisions by the same user not shown)
Line 1: Line 1:
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[ERGOMAR (ergotamine tartrate) tablet|{{fontcolor|#6C7B8B|ERGOMAR (ergotamine tartrate) tablet}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Ergotamine|{{fontcolor|#6C7B8B|Ergotamine}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ZZZZZ<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ERGOMAR (ergotamine tartrate) tablet<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet indications and usage|Indications and Usage]]
Line 36: Line 36:
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet labels and packages|Labels and Packages]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[ERGOMAR (ergotamine tartrate) tablet labels and packages|Labels and Packages]]
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on ERGOMAR (ergotamine tartrate) tablet
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Medihaler ergotamine (ergotamine tartrate) aerosol, metered<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered indications and usage|Indications and Usage]]
|-style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0";
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker] |{{fontcolor|#6C7B8B|medihaler ergotamine (ergotamine tartrate)  aerosol, metered  [3M Riker] }}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ZZZZZ<sup>®</sup> FDA Package Insert
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered dosage and administration|Dosage and Administration]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  indications and usage|Indications and Usage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered dosage forms and strengths|Dosage Forms and Strengths]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered contraindications|Contraindications]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  dosage forms and strengths|Dosage Forms and Strengths]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered warnings and precautions|Warnings and Precautions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  contraindications|Contraindications]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered adverse reactions|Adverse Reactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  warnings and precautions|Warnings and Precautions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered drug interactions|Drug Interactions]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  adverse reactions|Adverse Reactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered use in specific populations|Use in Specific Populations]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  drug interactions|Drug Interactions]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered overdosage|Overdosage]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  use in specific populations|Use in Specific Populations]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered description|Description]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered clinical pharmacology|Clinical Pharmacology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered nonclinical toxicology|Nonclinical Toxicology]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  clinical pharmacology|Clinical Pharmacology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  nonclinical toxicology|Nonclinical Toxicology]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered how supplied storage and handling|How Supplied/Storage and Handling]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  clinical studies|Clinical Studies]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered patient counseling information|Patient Counseling Information]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]  how supplied storage and handling|How Supplied/Storage and Handling]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[Medihaler ergotamine (ergotamine tartrate)  aerosol, metered labels and packages|Labels and Packages]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered  [3M Riker]  patient counseling information|Patient Counseling Information]]
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on Medihaler ergotamine (ergotamine tartrate)  aerosol, metered
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [[medihaler ergotamine (ergotamine tartrate)  aerosol, metered  [3M Riker]  labels and packages|Labels and Packages]]
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | Clinical Trials on medihaler ergotamine (ergotamine tartrate)  aerosol, metered [3M Riker]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left | [http://clinicaltrials.gov/search/open/condition={{urlencode:{{#if:{{{1|}}}|{{{1}}}|{{PAGENAME}}}}}} ClinicalTrials.gov]
|-
|-
|}
|}

Latest revision as of 22:59, 11 February 2014

Ergotamine
ERGOMAR (ergotamine tartrate) tablet® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Medihaler ergotamine (ergotamine tartrate) aerosol, metered® FDA Package Insert
Indications and Usage
Dosage and Administration
Dosage Forms and Strengths
Contraindications
Warnings and Precautions
Adverse Reactions
Drug Interactions
Use in Specific Populations
Overdosage
Description
Clinical Pharmacology
Nonclinical Toxicology
Clinical Studies
How Supplied/Storage and Handling
Patient Counseling Information
Labels and Packages
Clinical Trials on Medihaler ergotamine (ergotamine tartrate) aerosol, metered
ClinicalTrials.gov
Retrieved from "https://www.wikidoc.org/index.php?title=Template:Ergotamine&oldid=942533"